{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:27:08Z","timestamp":1760549228970},"reference-count":69,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2012,7,3]],"date-time":"2012-07-03T00:00:00Z","timestamp":1341273600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovascular Therapeutics"],"published-print":{"date-parts":[[2012,8]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>The Avoiding Cardiovascular Events through Combination Therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial showed that initial antihypertensive therapy with benazepril plus amlodipine was superior to benazepril plus hydrochlorothiazide in reducing progression of chronic kidney disease as well as cardiovascular morbidity and mortality in renal patients. The renal results of the ACCOMPLISH trial strongly support the recommendation of using calcium channel blockers as second antihypertensive agent added to renin\u2013angiotensin axis\u2010blocking drugs. This review discusses the validity of these data and their relationship with the cumulative evidence on the effects of calcium antagonists on renal disease progression.<\/jats:p>","DOI":"10.1111\/j.1755-5922.2010.00260.x","type":"journal-article","created":{"date-parts":[[2012,7,3]],"date-time":"2012-07-03T07:55:58Z","timestamp":1341302158000},"page":"193-198","source":"Crossref","is-referenced-by-count":14,"title":["Blood Pressure in Renal Disease: How to Accomplish the Goal?"],"prefix":"10.1111","volume":"30","author":[{"given":"Nicol\u00e1s R.","family":"Robles","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roman","family":"Hernandez\u2010Gallego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,7,3]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2003.50007"},{"key":"e_1_2_8_3_1","unstructured":"US Renal Data Systems.USRDS 2006 Annual Data Report: Atlas of End Stage Renal Diseases in the United States. In:National Institutes of Health. Bethesda MD .The National Institute of Diabetes and Digestive and Kidney Disease. Division of Kidney Urologic and Hematologic Diseases2006. Available from:http:\/\/www.usrds.org\/atlas_2006.htm[accessed 6 February 2010]."},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(98)70145-3"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000107251.49515.c2"},{"key":"e_1_2_8_6_1","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1097\/HJH.0b013e3282f0580f","article-title":"ESH\u2010ESC practice guidelines for the management of arterial hypertension: ESH\u2010ESC Task Force on the management of arterial hypertension","volume":"25","author":"Mancia G","year":"2007","journal-title":"J Hypertens"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.00840805"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.08.036"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/MNH.0b013e328309a497"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1177\/1470320310374215"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2006.10.014"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.00840805"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.38237.585000.7C"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0806182"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)62100-0"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1001286"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)71082-5"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2008.102"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1001410"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(03)00826-6"},{"issue":"39","key":"e_1_2_8_21_1","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification","volume":"1","author":"National Kidney Foundation","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.34.5.1129"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200103000-00020"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02527-7"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.23.2981"},{"key":"e_1_2_8_26_1","volume-title":"World Congress of Nephrology","author":"Changes in glomerular filtration rate with benazepril plus amlodipine or benazepril plus hydrochlorothiazide treatment in hypertensive patients at high risk; an analysis of the ACCOMPLISH trial","year":"2009"},{"key":"e_1_2_8_27_1","first-page":"163","volume-title":"Angiotensin converting enzyme inhibitors","author":"Robles NR","year":"2009"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.09911.x"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2009.04.029"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0801317"},{"key":"e_1_2_8_31_1","first-page":"247","volume-title":"Calcium antagonists and the kidney","author":"Reams GP","year":"1990"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1993.279"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1996.365"},{"key":"e_1_2_8_34_1","first-page":"F1015","article-title":"Disparate effects of Ca channel blockers on afferent and efferent arteriolar responses to ANG II","volume":"256","author":"Carmines PK","year":"1989","journal-title":"Am J Physiol"},{"key":"e_1_2_8_35_1","first-page":"33","volume-title":"Calcium antagonists and the kidney","author":"Loutzenhiser R","year":"1990"},{"key":"e_1_2_8_36_1","first-page":"F1157","article-title":"Calcium antagonists preferentially dilate preglomerular vessels of hydronephrotic kidney","volume":"253","author":"Fleming JT","year":"1987","journal-title":"Am J Physiol"},{"key":"e_1_2_8_37_1","first-page":"S21","article-title":"Effects of calcium channel blockers on glomerular injury on experimental glomerular injury","volume":"1","author":"Dworkin LD","year":"1990","journal-title":"J Am Soc Nephrol"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199403000-00018"},{"key":"e_1_2_8_39_1","first-page":"248","article-title":"Characterization of the renal action of pranidipine in the rat","volume":"50","author":"Nagahama T","year":"2000","journal-title":"Arzneimittel\u2010 Forsch"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.17.3.288"},{"key":"e_1_2_8_41_1","first-page":"F1003","article-title":"Renal autoregulation and vulnerability to hypertensive injury in remnant kidney","volume":"252","author":"Bidani AK","year":"1987","journal-title":"Am J Physiol"},{"key":"e_1_2_8_42_1","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1681\/ASN.V4122023","article-title":"Method of renal mass reduction is a critical determinant of subsequent hypertension and glomerular injury","volume":"4","author":"Griffin KA","year":"1994","journal-title":"J Am Soc Nephrol"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118125"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1999.00434.x"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00265948"},{"key":"e_1_2_8_46_1","first-page":"1638","article-title":"Effect of nilvadipine on renal function in normal man","volume":"44","author":"Allison N","year":"1985","journal-title":"Fed Proc"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199206000-00002"},{"key":"e_1_2_8_48_1","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/00005344-199212000-00008","article-title":"Effects of manidipine hydrochloride on the renal microcirculation in spontaneously hypertensive rats","volume":"20","author":"Tojo A","year":"1992","journal-title":"J Cardiovasc Pharmacol"},{"key":"e_1_2_8_49_1","first-page":"S132","article-title":"Diverse effects of calcium antagonists on glomerular hemodynamics","volume":"55","author":"Arima S","year":"1996","journal-title":"Kidney Int"},{"key":"e_1_2_8_50_1","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.25.571"},{"key":"e_1_2_8_51_1","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.19.31"},{"issue":"49","key":"e_1_2_8_52_1","first-page":"S52","article-title":"Antihypertensive agents and renal protection: Calcium channel blockers","volume":"55","author":"Saruta T","year":"1996","journal-title":"Kidney Int"},{"key":"e_1_2_8_53_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199902000-00010"},{"key":"e_1_2_8_54_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.38.3.343"},{"key":"e_1_2_8_55_1","doi-asserted-by":"publisher","DOI":"10.1081\/JDI-120024284"},{"key":"e_1_2_8_56_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-005-0961-2"},{"key":"e_1_2_8_57_1","first-page":"261","article-title":"Efficacy and tolerability of manidipine in the treatment of hypertension in patients with non\u2010diabetic chronic kidney disease without glomerular disease. Prospective, randomized, double\u2010blind study of parallel groups in comparison with enalapril","volume":"17","author":"Del Vecchio L","year":"2004","journal-title":"J Nephrol"},{"key":"e_1_2_8_58_1","first-page":"259","article-title":"Effect of lercanidipine compared with ramipril on albumin excretion rate in hypertensive type II diabetic patients with microalbuminuria: DIAL Study (diabete, ipertensione, albuminuria, lercanidipina). Diab","volume":"17","author":"Dalla Vestra M","year":"2004","journal-title":"Nutr Metab"},{"key":"e_1_2_8_59_1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1081\/JDI-42801","article-title":"Lercanidipine in chronic renal failure patients: The ZAFRA Study","volume":"27","author":"Robles NR","year":"2005","journal-title":"Ren Fail"},{"key":"e_1_2_8_60_1","doi-asserted-by":"publisher","DOI":"10.3109\/08860220903541135"},{"key":"e_1_2_8_61_1","doi-asserted-by":"publisher","DOI":"10.1080\/10641960802251941"},{"key":"e_1_2_8_62_1","first-page":"S13","article-title":"Interactions of the endothelium and mesangium in glomerular injury","volume":"1","author":"Sweeney C","year":"1990","journal-title":"J Am Soc Nephrol"},{"key":"e_1_2_8_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(85)90076-2"},{"key":"e_1_2_8_64_1","doi-asserted-by":"publisher","DOI":"10.1159\/000045633"},{"key":"e_1_2_8_65_1","doi-asserted-by":"publisher","DOI":"10.1159\/000065266"},{"key":"e_1_2_8_66_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.9.4071"},{"key":"e_1_2_8_67_1","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.23.521"},{"key":"e_1_2_8_68_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000021924.02006.BA"},{"key":"e_1_2_8_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(97)00158-7"},{"key":"e_1_2_8_70_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.fjc.0000211750.01326.b3"}],"container-title":["Cardiovascular Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1755-5922.2010.00260.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1755-5922.2010.00260.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T02:00:15Z","timestamp":1698717615000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1755-5922.2010.00260.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,3]]},"references-count":69,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["10.1111\/j.1755-5922.2010.00260.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1755-5922.2010.00260.x","archive":["Portico"],"relation":{},"ISSN":["1755-5914","1755-5922"],"issn-type":[{"value":"1755-5914","type":"print"},{"value":"1755-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,3]]}}}